Hair loss in men is predominantly genetic and most commonly occurs between the ages of 18 and 65. This condition, medically referred to as male pattern baldness or androgenetic alopecia, follows a characteristic progression that can vary significantly from one individual to another.
The primary underlying cause is the hormone dihydrotestosterone (DHT), which affects genetically susceptible hair follicles, causing them to progressively shrink and, over time, cease producing healthy hair. Male pattern baldness accounts for approximately 90–95% of all hair and scalp concerns in men.
The primary cause is the hormone dihydrotestosterone (DHT), which targets genetically susceptible hair follicles, causing them to shrink and eventually die. Male pattern baldness accounts for 90-95% of hair and scalp issues in men.
By the age of 35, nearly two-thirds of men will experience some degree of hair loss. By 50, this figure rises to approximately 85%, with many men noticing significant thinning, particularly along the hairline and crown.
Beyond the physical changes, hair loss can have a meaningful impact on a man’s confidence, self-image, and professional presence, sometimes contributing to social withdrawal and reduced self-esteem.
Unfortunately, many men are misinformed or misdiagnosed, leading them to rely on ineffective solutions such as topical shampoos or low-level laser devices that do not provide predictable or long-term results. Proper medical assessment and evidence-based treatment are essential for achieving lasting and natural outcomes.
Hair loss in women, while less common than in men, is often more emotionally distressing due to differing genetic patterns and societal perceptions. Unlike male hair loss, female hair loss is typically gradual and diffuse, making it less noticeable initially but more impactful over time.
In advanced stages, female androgenetic alopecia may present as visible thinning or a bald area at the top of the scalp, significantly affecting self-esteem and quality of life. Although frequently misunderstood as a predominantly male condition, androgenetic hair loss affects approximately 30–40% of women.
The stigma surrounding female hair loss often leads women to suffer in silence or turn to temporary cosmetic solutions such as wigs, extensions, or so-called miracle treatments, which may mask symptoms while potentially causing further long-term damage.
Hair loss in women may be temporary or permanent, depending on the underlying cause and how early it is correctly diagnosed and treated. Hormonal changes—particularly during and after menopause—are a common contributing factor, and the severity of hair loss may fluctuate seasonally.
Additional influences include oral contraceptives, hormonal therapies, pregnancy, stress, and nutritional deficiencies such as low levels of vitamin B, iron, zinc, or magnesium. The most common hereditary cause, female pattern hair loss, is linked to androgen sensitivity. Although women produce significantly lower levels of androgens than men, a genetic predisposition can still trigger follicle miniaturisation.
Over time, this process accelerates the hair growth cycle, reduces the hair’s regenerative capacity, and results in progressively finer strands that may eventually stop growing altogether.
